BCAR3 and neoplasm: Univariate analysis from 121 EOC patients with either low (n = 52) and high (n = 69) MIG-7 expression revealed that the 5-year OS for patients with high and low tumor MIG-7 expression was 39.39% and 65.15%, respectively (p < 0.0001) (Figure 5E and Table 2).